Skip to main content
. Author manuscript; available in PMC: 2017 Sep 12.
Published in final edited form as: Obesity (Silver Spring). 2016 Oct 18;24(12):2608–2614. doi: 10.1002/oby.21678

TABLE 1.

Demographic and clinical characteristics of the PONS participants

N=11,308
Age (years) 55.6 (5.4)
Men, N (%) 3,663 (32.4)
Smoking, current, N (%) 2,216 (19.6)
Systolic blood pressure (mm Hg) 137.6 (19.2)
Diastolic blood pressure (mm Hg) 82.2 (10.6)
Total cholesterol (mg/dL) 210.1 (38.5)
LDL cholesterol (mg/dL) 127.2 (33.9)
HDL cholesterol (mg/dL) 59.1 (14.6)
Metabolic syndrome, N (%) 4,382 (38.8)
Hypertension, N (%) 4,390 (38.8)
Diabetes, N (%) 687 (6.1)
Total cardiovascular diseases, N (%) 1,528 (13.5)
Obesity measures
BMI (kg/m2) 28.2 (4.7)
  BMI24.9 2,916 (25.8)
  BMI 25–29.9 4,935 (43.6)
  BMI30 3,457 (30.6)
Waist circumference (cm) 91.8 (12.5)
Increased waist circumference, N (%) 5,147 (45.5)
Waist-hip ratio 0.89 (0.1)
ECG measures
P-wave duration (ms) 106.7 (16.3)
PR interval duration (ms) 156.3 (24.3)
Heart rate (bpm) 67 (10)
QRS duration (ms) 92.7 (9.4)
QT interval duration (ms) 418.7 (30.8)
Left axis deviation, N (%) 695 (6.1)
LVH, N (%) 379 (3.4)
Intraventricular conduction defects, N (%)
  QRS120 ms 88 (0.8)
  Right bundle branch block (complete and incomplete) 1,590 (14.1)
  Left bundle branch block 10 (0.1)
Pathological Q wave, N (%) 772 (6.8)
T-wave inversion, N (%) 572 (5.1)

Values are means (SD) except as noted.

LDL, low-density lipoprotein; HDL, high-density lipoprotein; BMI, body mass index; ECG, electrocardiogram; LVH, left ventricular hypertrophy.